Rivory LP - Search Results

1

Predicting the toxicity of weekly docetaxel in advanced cancer.

Charles KA, Rivory LP, Stockler MR, Beale P, Beith J, Boyer M, Clarke SJ. Charles KA, et al. Among authors: rivory lp. Clin Pharmacokinet. 2006;45(6):611-22. doi: 10.2165/00003088-200645060-00004. Clin Pharmacokinet. 2006. PMID: 16719542 Clinical Trial.

2

Clinical pharmacokinetics of docetaxel.

Clarke SJ, Rivory LP. Clarke SJ, et al. Among authors: rivory lp. Clin Pharmacokinet. 1999 Feb;36(2):99-114. doi: 10.2165/00003088-199936020-00002. Clin Pharmacokinet. 1999. PMID: 10092957 Review.

3

Clinical and preclinical pharmacokinetics of raltitrexed.

Clarke SJ, Beale PJ, Rivory LP. Clarke SJ, et al. Among authors: rivory lp. Clin Pharmacokinet. 2000 Dec;39(6):429-43. doi: 10.2165/00003088-200039060-00004. Clin Pharmacokinet. 2000. PMID: 11192475 Review.

4

A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer.

Sharma R, Rivory L, Beale P, Ong S, Horvath L, Clarke SJ. Sharma R, et al. Br J Cancer. 2006 Apr 10;94(7):964-8. doi: 10.1038/sj.bjc.6603049. Br J Cancer. 2006. PMID: 16552436 Free PMC article. Clinical Trial.

5

Population pharmacokinetics of weekly docetaxel in patients with advanced cancer.

Slaviero KA, Clarke SJ, McLachlan AJ, Blair EY, Rivory LP. Slaviero KA, et al. Among authors: rivory lp. Br J Clin Pharmacol. 2004 Jan;57(1):44-53. doi: 10.1046/j.1365-2125.2003.01956.x. Br J Clin Pharmacol. 2004. PMID: 14678339 Free PMC article. Clinical Trial.

6

Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.

Blair EY, Rivory LP, Clarke SJ, McLachlan AJ. Blair EY, et al. Among authors: rivory lp. Br J Clin Pharmacol. 2004 Apr;57(4):416-26. doi: 10.1111/j.1365-2125.2003.02050.x. Br J Clin Pharmacol. 2004. PMID: 15025739 Free PMC article. Clinical Trial.

7

Optimizing the erythromycin breath test for use in cancer patients.

Rivory LP, Slaviero K, Seale JP, Hoskins JM, Boyer M, Beale PJ, Millward MJ, Bishop JF, Clarke SJ. Rivory LP, et al. Clin Cancer Res. 2000 Sep;6(9):3480-5. Clin Cancer Res. 2000. PMID: 10999732 Clinical Trial.

8

The erythromycin breath test for the prediction of drug clearance.

Rivory LP, Slaviero KA, Hoskins JM, Clarke SJ. Rivory LP, et al. Clin Pharmacokinet. 2001;40(3):151-8. doi: 10.2165/00003088-200140030-00001. Clin Pharmacokinet. 2001. PMID: 11327195 Review.

9

Toxicity of irinotecan (CPT-11) and hepato-renal dysfunction.

Ong SY, Clarke SJ, Bishop J, Dodds HM, Rivory LP. Ong SY, et al. Among authors: rivory lp. Anticancer Drugs. 2001 Aug;12(7):619-25. doi: 10.1097/00001813-200108000-00009. Anticancer Drugs. 2001. PMID: 11487719

10

Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules.

Li KM, Rivory LP, Clarke SJ. Li KM, et al. Among authors: rivory lp. Br J Cancer. 2007 Oct 22;97(8):1071-6. doi: 10.1038/sj.bjc.6603995. Epub 2007 Oct 2. Br J Cancer. 2007. PMID: 17912246 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters